KRISTOPHER STEINKE: Open Payments
NPI 1558375642 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$511 in 24 payments from 8 companies in 2025. Trend: 2023 $902 · 2024 $707 · 2025 $511
Food & beverage: $511
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $159 |
| Neurocrine BioSciences, Inc. | 6 | $144 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| Lundbeck LLC | 2 | $44 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $17 |
Products named: INGREZZA, UZEDY, AUSTEDO XR, CAPLYTA, ABILIFY ASIMTUFII, INVEGA SUSTENNA, COBENFY, Auvelity.
Industry payments across TX — which companies pay providers there.
